In Brief: Research Industries Corp.
This article was originally published in The Gray Sheet
Executive Summary
Research Industries Corp.: Biomedical firm acquires catheter manufacturer Imodex in a "pooling of interests transaction" valued at approximately $388,000. The deal will give Salt Lake City-based RIC's recently formed vascular division its second product line, Imodex' cartoid artery balloon shunts for use in endarectomies. In November 1994, the division began rolling out its first product, the IschemiaAlert peripheral vascular perfusion sensor ("The Gray Sheet" Nov. 7, 1994, In Brief)...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.